Next-Generation Sequencing of Cancer Genomes: Lessons Learned

References

• Metzker ML . Sequencing technologies - the next generation. Nat. Rev. Genet.11(1), 31–46 (2010).
   PubMed Web of Science ®Google Scholar
• Mardis ER . A decade's perspective on DNA sequencing technology. Nature470(7333), 198–203 (2011).
   PubMed Web of Science ®Google Scholar
• Thompson JF , MilosPM. The properties and applications of single-molecule DNA sequencing. Genome Biol.12(2), 217 (2011).
   PubMed Web of Science ®Google Scholar
• Hammerman PS , LawrenceMS, VoetDet al. Comprehensive genomic characterization of squamous cell lung cancers. Nature489(7417), 519–525 (2012).
   PubMed Web of Science ®Google Scholar
• Shackleton M , QuintanaE, FearonER, MorrisonSJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell138(5), 822–829 (2009).
   PubMed Web of Science ®Google Scholar
• Meacham CE , MorrisonSJ. Tumor heterogeneity and cancer cell plasticity. Nature501(7467), 328–337 (2013).
   PubMed Web of Science ®Google Scholar
• Burrell RA , McGranahanN, BartekJ, SwantonC. The causes and consequences of genetic heterogeneity in cancer evolution. Nature501(7467), 338–345 (2013).
   PubMed Web of Science ®Google Scholar
• Dagogo-Jack I , ShawAT. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol.15(2), 81–94 (2018).
   PubMed Web of Science ®Google Scholar
• Sun X , YuQ. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol. Sin.36(10), 1219–1227 (2015).
   PubMed Web of Science ®Google Scholar
• Akbani R , NgPKS, WernerHMJet al. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun.5, 3887 (2014).
   PubMed Web of Science ®Google Scholar
• Gyanchandani R , LinY, LinH-Met al. Intratumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer. Clin. Cancer Res.22(21), 5362–5369 (2016).
   PubMed Web of Science ®Google Scholar
• Yun JW , LeeS, RyuDet al. Biomarkers associated with tumor heterogeneity in prostate cancer. Transl. Oncol.12(1), 43–48 (2018).
   PubMed Web of Science ®Google Scholar
• Charoentong P , FinotelloF, AngelovaMet al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep.18(1), 248–262 (2017).
   PubMed Web of Science ®Google Scholar
• McGranahan N , FaveroF, de BruinEC, BirkbakNJ, SzallasiZ, SwantonC. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci. Transl. Med.7(283), 283ra54 (2015).
   PubMed Web of Science ®Google Scholar
• McGranahan N , SwantonC. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell168(4), 613–628 (2017).
   PubMed Web of Science ®Google Scholar
• Farooqui MZH , ValdezJ, MartyrSet al. Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial. Lancet Oncol.16(2), 169–176 (2015).
   PubMed Web of Science ®Google Scholar
• Ahn IE , UnderbayevC, AlbitarAet al. Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia. Blood129(11), 1469–1479 (2017).
   PubMed Web of Science ®Google Scholar
• Famà R , BombenR, RasiSet al. Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. Blood124(25), 3831–3833 (2014).
   PubMed Web of Science ®Google Scholar
• Bedard PL , HansenAR, RatainMJ, SiuLL. Tumour heterogeneity in the clinic. Nature501(7467), 355–364 (2013).
   PubMed Web of Science ®Google Scholar
• Ramón y Cajal S , SeséM, CapdevilaCet al. Clinical implications of intratumor heterogeneity: challenges and opportunities. J. Mol. Med. (Berl)98(2), 161–177 (2020).
   PubMed Web of Science ®Google Scholar
• Hiley CT , SwantonC. Spatial and temporal cancer evolution: causes and consequences of tumour diversity. Clin Med.14(Suppl. 6), S33–S37 (2014).
   PubMedGoogle Scholar
• Bardelli A , PantelK. Liquid biopsies, what we do not know (yet). Cancer Cell.31(2), 172–179 (2017).
   PubMed Web of Science ®Google Scholar
• Váraljai R , HornS, SuckerAet al. Integrative genomic analyses of patient-matched intracranial and extracranial metastases reveal a novel brain-specific landscape of genetic variants in driver genes of malignant melanoma. Cancers (Basel).13(4), 731 (2021).
   PubMed Web of Science ®Google Scholar
• Vignot S , FramptonGM, SoriaJ-Cet al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J. Clin. Oncol.31(17), 2167–2172 (2013).
   PubMed Web of Science ®Google Scholar
• Brannon AR , VakianiE, SylvesterBEet al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol.15(8), 454 (2014).
   PubMed Web of Science ®Google Scholar
• Fares J , FaresMY, KhachfeHH, SalhabHA, FaresY. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct. Target Ther.5, 28 (2020).
   PubMed Web of Science ®Google Scholar
• Marusyk A , AlmendroV, PolyakK. Intra-tumour heterogeneity: a looking glass for cancer?Nat. Rev. Cancer.12(5), 323–334 (2012).
   PubMed Web of Science ®Google Scholar
• Eccles A , ChallapalliA, KhanS, BarwickT, MangarS. Thyroid lymphoma incidentally detected by 18F-fluorocholine (FCH) PET/CT. Clin. Nucl. Med.38(9), 755–757 (2013).
   PubMed Web of Science ®Google Scholar
• Nakagawa H , FujitaM. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci.109(3), 513–522 (2018).
   PubMed Web of Science ®Google Scholar
• Colomer R , MondejarR, Romero-LaordenN, AlfrancaA, Sanchez-MadridF, Quintela-FandinoM. When should we order a next generation sequencing test in a patient with cancer?E. Clinical Medicine25(100487), (2020).
   Google Scholar